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addition, different kinds of neuropathies are one of the 
major complications contributing to morbidity in pa-
tients with diabetes mellitus. Pathological studies have 
also suggested that diabetes is one of the risk factors 
for senile dementia of Alzheimer’s type (4). Although 
many studies about the relationship between diabetes 
and peripheral neuropathy have been done to date, how-
ever, the effects and consequences of diabetes on the 
brain itself have not been much studied and no marked 
structural abnormality has been found in the central 
nervous system of patients with diabetic neuropathy 
using routine staining methods (5). Functionally, pas-
              1. Introduction
iabetes mellitus (DM) has been associated 
with neurological complications in both the 
peripheral and the central nervous system 
(1). Long-term DM leads to a wide range 
of peripheral neuronal deficits including re-
duced motor nerve conduction velocity, impaired nerve 
regeneration, axonal shrinkage, and deficient axonal 
transport (2). In streptozotocin (STZ)-diabetic rats, the 
nerve damage observed parallels in many ways the nerve 
degeneration seen in human diabetic neuropathy (3). In 
D
Introduction: Diabetes mellitus is accompanied with disturbances in learning, 
memory, and cognitive skills in the human society and experimental animals. 
Due to anti-diabetic and antioxidant activity of Rumex patientia (RP), this 
research study was conducted to evaluate the efficacy of chronic Rumex patientia 
feeding on alleviation of learning and memory disturbance in streptozotocin-
diabetic rats. 
Methods: Male Wistar rats were divided into control, diabetic, RP-treated-
control and -diabetic groups. For induction of diabetes, streptozotcin (STZ) was 
administered at a dose of 60 mg/Kg. Meanwhile, RP-treated groups received 
RP seed powder mixed with standard pelleted food at a weight ratio of 6% 
for 4 weeks. For evaluation of learning and memory, initial latency (IL) and 
step-through latency (STL) were determined at the end of study using passive 
avoidance test. 
Results: It was found out that regarding initial latency, there was no significant 
difference among the groups. In addition, diabetic rats developed a significant 
impairment in retention and recall in passive avoidance test (p<0.01), as it is 
evident by a lower STL. Furthermore, RP treatment of diabetic rats did produce 
a significant improvement in retention and recall (p<0.05).
Discussion: Taken together, chronic RP feeding could improve retention and 
recall capability in passive avoidance test in STZ-diabetic rats. 
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sive avoidance learning and memory deficits develop in 
STZ-diabetic rats (6). Impairment of spatial learning in 
a hippocampus-dependent complex maze has also been 
reported in such animals (7). Changes in hippocampal 
synaptic plasticity have been reported in diabetes (8). 
These findings suggest that untreated diabetes results 
in deficits across multiple neural systems underlying 
learning and memory processes.
On the other hand, recent interests are focusing on the 
use of medicinal plants with antidiabetic and antioxi-
dant potential in reducing the ensuing complications in 
diabetic patients (9). Plant-based pharmaceuticals have 
been employed in the management of various mankind 
diseases (10). They are as essential part of human diet 
and are present in plant extracts that have been used 
for centuries in oriental medicine. Antioxidant proper-
ties, ROS scavenging and cell function modulation of 
medicinal plants and their effective substances could 
account for the large part of their pharmacological ac-
tivity (11-12). Antioxidant and free radical scavenging 
activity (13), gastroprotective and anti-ulcerogenic ac-
tivity in gastric tissue (14), protecting pancreatic B cells 
against STZ-induced damage (15), and anti-inflamma-
tory effect (16) of Rumex patientia (RP) have already 
been reported. In addition, Rumex patientia seed (grain) 
aqueous extract has been used for the treatment of type 
I diabetes induced by STZ (17). Therefore, this study 
was undertaken to evaluate the efficacy of chronic RP 
on alleviation of learning and memory disturbance in 
streptozotocin-diabetic rats using passive avoidance. 
2. Methods
2.1. Animals
Male albino Wistar rats (Pasteur’s institute, Tehran, 
Iran) weighing 265 ± 13 g (11-13 weeks old) were 
housed in an air-conditioned colony room on a light/
dark cycle (21-23 oC and a humidity of 30-40%) and 
supplied with standard pelleted diet and tap water ad 
libitum. Procedures involving animals and their care 
were conducted in conformity with the NIH guidelines 
for the care and use of laboratory animals.
2.2. Experimental Procedure
The rats (n = 32) were randomly allocated and simi-
larly grouped into four groups: normal vehicle-treated 
control, RP-treated control, vehicle-treated diabetic and 
RP-treated diabetic. The rats were rendered diabetic by a 
single intraperitoneal injection of 60 mg kg-1 streptozo-
tocin (STZ) (Pharmacia and Upjohn, USA) freshly dis-
solved in cold normal saline. Control animals received 
an injection of an equivalent volume of normal saline 
and vehicle. Diabetes was confirmed by the presence 
of hyperglycemia, polyphagia, polydipsia, polyuria and 
weight loss. One week after STZ injection, blood sam-
ples were collected and serum glucose concentrations 
were measured using glucose oxidation method (Zist-
shimi, Tehran). Only those animals with serum glucose 
higher than 250 mg dl-1 were selected as diabetics for 
the following experiments. The day on which hyperg-
lycemia had been confirmed was designated as day 0. 
Rumex patientia seed was prepared, dried under shade 
and finally ground. Plant-mixed food pellet at a weight 
ratio of 6% was prepared using pellet-making device 
(Nooran Co., Tehran). This ratio was chosen accord-
ing to our pilot study. Changes in body weight, food 
consumption and water intake were regularly observed 
during the experimental period. Behavioral test (passive 
avoidance) was performed at the end of study in experi-
mental groups as described below. 
2.3. Single-trial Passive Avoidance Test
The apparatus (BPT Co., Tehran) consisted of an illu-
minated chamber connected to dark chamber by a guil-
lotine door. Electric shocks were delivered to the grid 
floor by an isolated stimulator. On the first and second 
days of testing, each rat was placed on the apparatus 
and left for 5 min to habituate to the apparatus. On the 
third day, an acquisition trial was performed. Rats were 
individually placed in the illuminated chamber. After 
a habituation period (5 min), the guillotine door was 
opened and after the rat entering the dark chamber, the 
door was closed and an inescapable scrambled electric 
shock (1 mA, 1 s once) was delivered. In this trial, the 
initial latency (IL) of entrance into the dark chamber 
was recorded and rats with ILs greater than 60 s were 
excluded form the study. Twenty-four hours later, each 
rat was placed in the illuminated chamber for retention 
trial. The interval between the placement in the illumi-
nated chamber and the entry into the dark chamber was 
measured as step-through latency (STL up to a maxi-
mum of 600 s as cut-off).
2.4. Statistical Analysis
All results were expressed as mean ± S.E.M. For be-
havioral test, parametric one-way ANOVA test was ap-
plied. Body weight and serum glucose levels at different 
weeks were analyzed using repeated measure one-way 
ANOVA. In all calculations, a difference at p<0.05 was 
regarded as significant. 
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3. Results
Body weight and serum glucose measurements (Fig. 
1) indicated that before diabetes induction, there were 
no significant differences among experimental groups. 
After 4 weeks, the weight of the vehicle-treated diabetic 
rats was found to be significantly decreased as com-
pared to control rats (p<0.05) and RP-treated diabetics 
showed a less non-significant decrease as compared to 
vehicle-treated diabetics. Untreated diabetic rats had 
also an elevated serum glucose level over those of con-
trol rats (p<0.001) and treatment of diabetic rats with 
RP caused a significant decrease in the serum glucose 
(p<0.05) only at 2nd week relative to vehicle-treated 
diabetics. In addition, RP treatment of control rats did 
not produce any significant change regarding serum 
glucose level.
Fig. 2 shows the performance of treated-control and 
diabetic rats in passive avoidance paradigm as indicated 
by initial and step-through latencies. Regarding initial 
latency, there was no significant difference among the 
groups. In addition, diabetic-treated rats developed a 
significant impairment in retention and recall in passive 
avoidance test (p<0.01), as it is evident by a lower STL 
and RP treatment did produce a significant improve-
ment (p<0.05).  Furthermore, retention and recall of RP-
treated control rats was not affected by RP treatment.
4. Discussion
The main findings of this study were two-fold. First, 
long-term diabetes was accompanied with disturbances in 
animal performance in passive avoidance as was evident 
by a lower STL. Second, 4-week administration of RP 
improved could prevent retention and recall abnormality 
in diabetic rats as evaluated by passive avoidance test. 
Although the multifactorial pathogenesis of cognitive 
and memory impairments in diabetes has not yet com-
pletely understood, several factors such as metabolic 
impairments, vascular complications as well as release 
of free radicals have been implicated (18). First, pro-
longed hyperglycemia is a primary cause of most com-
plications of diabetes. Indeed, chronic hyperglycemia 
is thought to lead to cognitive impairments in diabe-
tes (19). Hyperglycemia in type I diabetic patients has 
also been associated with learning impairments (20). 
Fig. 1. 
* p<0.05, ** p<0.01, *** p<0.001 (as compared to baseline in the same group); § p<0.05, §§ p<0.01 
(as compared to diabetic in the same week)
Fig. 2. Initial (IL) and step-through (STL) latencies of 
treated-control and -diabetic rats in single-trial passive 
avoidance test
* p<0.05, ** p<0.01 (vs. control)
# p<0.05 (vs. diabetic) 
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Therefore, the restoration of some cognitive functions 
observed in diabetic animals in this study may be partly 
due to the ability of RP to attenuate hyperglycemia, as 
observed in this study. Second, brain vascular abnor-
malities may also contribute to the pathophysiology of 
cognitive impairment in diabetes (20). Third, oxidative 
damage is associated with cognitive dysfunction (20), 
therefore treatment with antioxidants could be a thera-
peutic approach in various types of neurodegenerative 
diseases (20). Oxidative stress contributes to increased 
neuronal damage and death through protein oxidation, 
DNA damage, and peroxidation of membrane lipids 
(20). It has been observed that use of antioxidants and 
neuroprotective agents may decrease the risk of memo-
ry deficits (21). 
In conclusion, chronic RP feeding could improve re-
tention and recall capability in passive avoidance test 
in STZ-diabetic rats. Further studies are warranted to 
investigate the detailed involved mechanisms.
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